Intestinal Ischemia-reperfusion Induces the Release of IL-17A to Regulate Cell Inflammation, Apoptosis and Barrier Damage

Overview

Journal Exp Ther Med

Specialty Pathology

Date 2022 Jan 24

PMID 35069839

Authors

Li Xiao

Wan-Hua Zhang

Yin Huang

Peng Huang

Affiliations

Soon will be listed here.

Abstract

Intestinal ischemia-reperfusion (I/R) injury promotes the release of IL-17A, and previous studies have indicated that TGF-β activated kinase 1 (TAK1) is an important signaling molecule in the regulatory function of IL-17A. The present study aimed to explore the potential effects of IL-17A release in intestinal I/R injury, and to investigate the underlying regulatory mechanisms. Initially, the expression levels of TAK1 and JNK in a hypoxia/reoxygenation model were determined, and the effects of TAK1-knockdown on JNK phosphorylation and the viability, inflammation, apoptosis and barrier function of Caco-2 cells were assessed using Cell Counting Kit-8, reverse transcription-quantitative PCR, TUNEL and transepithelial electrical resistance assays, respectively. Subsequently, an antibody targeting IL-17A was used, and the effects of the IL-17A antibody on the expression levels of TAK1 as well as cell viability, inflammation, apoptosis and barrier function were determined. The results of the present study demonstrated that TAK1-knockdown markedly reduced JNK phosphorylation and improved the levels of cell viability, inflammation, apoptosis and barrier function via the MAPK signaling pathway. In addition, treatment with the IL-17A antibody inhibited the expression of TAK1, and reversed the aforementioned effects of TAK1 on Caco-2 cells. In conclusion, intestinal I/R induces the release of IL-17A to regulate cell viability, inflammation, apoptosis and barrier damage via the TAK1/MAPK signaling pathway.

Citing Articles

Combined effect of intermittent hemostasis and a modified external hemorrhage control device in a lethal swine model.

Zhang H, Guo Y, Zhao D, Huang X, Li Y, Zhang L Heliyon. 2024; 10(17):e37017.

PMID: 39296135 PMC: 11408843. DOI: 10.1016/j.heliyon.2024.e37017.

References

Hiebl V, Schachner D, Ladurner A, Heiss E, Stangl H, Dirsch V . Caco-2 Cells for Measuring Intestinal Cholesterol Transport - Possibilities and Limitations. Biol Proced Online. 2020; 22:7. PMC: 7149936. DOI: 10.1186/s12575-020-00120-w. View

Prete R, Garcia-Gonzalez N, Di Mattia C, Corsetti A, Battista N . Food-borne Lactiplantibacillus plantarum protect normal intestinal cells against inflammation by modulating reactive oxygen species and IL-23/IL-17 axis. Sci Rep. 2020; 10(1):16340. PMC: 7529774. DOI: 10.1038/s41598-020-73201-1. View

Fernandez A, Sanchez-Tarjuelo R, Cravedi P, Ochando J, Lopez-Hoyos M . Review: Ischemia Reperfusion Injury-A Translational Perspective in Organ Transplantation. Int J Mol Sci. 2020; 21(22). PMC: 7696417. DOI: 10.3390/ijms21228549. View

Li C, Li Q, Liu Y, Wang M, Pan C, Yan L . Protective effects of Notoginsenoside R1 on intestinal ischemia-reperfusion injury in rats. Am J Physiol Gastrointest Liver Physiol. 2013; 306(2):G111-22. DOI: 10.1152/ajpgi.00123.2013. View

Saleh H, El-Shorbagy H . Mechanism underlying methyl eugenol attenuation of intestinal ischemia/reperfusion injury. Appl Physiol Nutr Metab. 2017; 42(10):1097-1105. DOI: 10.1139/apnm-2017-0043. View

Zepp J, Wu L, Li X . IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease. Trends Immunol. 2011; 32(5):232-9. PMC: 3329781. DOI: 10.1016/j.it.2011.02.007. View

Tuncer F, Durmus Kocaaslan F, Yildirim A, Sacak B, Arabaci Tamer S, Sahin H . Ischemic Preconditioning and Iloprost Reduces Ischemia-Reperfusion Injury in Jejunal Flaps: An Animal Model. Plast Reconstr Surg. 2019; 144(1):124-133. DOI: 10.1097/PRS.0000000000005708. View

Kajino-Sakamoto R, Inagaki M, Lippert E, Akira S, Robine S, Matsumoto K . Enterocyte-derived TAK1 signaling prevents epithelium apoptosis and the development of ileitis and colitis. J Immunol. 2008; 181(2):1143-52. PMC: 3065656. DOI: 10.4049/jimmunol.181.2.1143. View

Radak D, Katsiki N, Resanovic I, Jovanovic A, Sudar-Milovanovic E, Zafirovic S . Apoptosis and Acute Brain Ischemia in Ischemic Stroke. Curr Vasc Pharmacol. 2016; 15(2):115-122. DOI: 10.2174/1570161115666161104095522. View

10.

Liu L, Yao J, Li Z, Zu G, Feng D, Li Y . miR-381-3p knockdown improves intestinal epithelial proliferation and barrier function after intestinal ischemia/reperfusion injury by targeting nurr1. Cell Death Dis. 2018; 9(3):411. PMC: 5852084. DOI: 10.1038/s41419-018-0450-z. View

11.

Subramanian S, Geng H, Tan X . Cell death of intestinal epithelial cells in intestinal diseases. Sheng Li Xue Bao. 2020; 72(3):308-324. PMC: 7755516. View

12.

McGeachy M, Cua D, Gaffen S . The IL-17 Family of Cytokines in Health and Disease. Immunity. 2019; 50(4):892-906. PMC: 6474359. DOI: 10.1016/j.immuni.2019.03.021. View

13.

Tang L, Zhou Y, Xiong X, Li N, Zhang J, Luo X . Ubiquitin-specific protease 7 promotes ferroptosis via activation of the p53/TfR1 pathway in the rat hearts after ischemia/reperfusion. Free Radic Biol Med. 2020; 162:339-352. DOI: 10.1016/j.freeradbiomed.2020.10.307. View

14.

Li J, Liu L, Zhao Q, Chen M . Role of Interleukin-17 in Pathogenesis of Intestinal Fibrosis in Mice. Dig Dis Sci. 2019; 65(7):1971-1979. DOI: 10.1007/s10620-019-05969-w. View

15.

Zhou J, An C, Jin X, Hu Z, Safirstein R, Wang Y . TAK1 deficiency attenuates cisplatin-induced acute kidney injury. Am J Physiol Renal Physiol. 2019; 318(1):F209-F215. PMC: 6985823. DOI: 10.1152/ajprenal.00516.2019. View

16.

Huang F, Kao C, Wachi S, Thai P, Ryu J, Wu R . Requirement for both JAK-mediated PI3K signaling and ACT1/TRAF6/TAK1-dependent NF-kappaB activation by IL-17A in enhancing cytokine expression in human airway epithelial cells. J Immunol. 2007; 179(10):6504-13. DOI: 10.4049/jimmunol.179.10.6504. View

17.

Ali M, Pham A, Wang X, Wolfram J, Pham S . Extracellular vesicles for treatment of solid organ ischemia-reperfusion injury. Am J Transplant. 2020; 20(12):3294-3307. DOI: 10.1111/ajt.16164. View

18.

Yang B, Zhang L, Chen Y, Bai Y, Jia J, Feng J . Melatonin alleviates intestinal injury, neuroinflammation and cognitive dysfunction caused by intestinal ischemia/reperfusion. Int Immunopharmacol. 2020; 85:106596. DOI: 10.1016/j.intimp.2020.106596. View

19.

Ming Y, Chao H, Chu S, Luo C . Heparin-binding epidermal growth factor-like growth factor (HB-EGF) protected intestinal ischemia-reperfusion injury through JNK and p38/MAPK-dependent pathway for anti-apoptosis. Pediatr Neonatol. 2018; 60(3):332-336. DOI: 10.1016/j.pedneo.2018.08.003. View

20.

Feng D, Yao J, Wang G, Li Z, Zu G, Li Y . Inhibition of p66Shc-mediated mitochondrial apoptosis via targeting prolyl-isomerase Pin1 attenuates intestinal ischemia/reperfusion injury in rats. Clin Sci (Lond). 2017; 131(8):759-773. DOI: 10.1042/CS20160799. View